Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

By M. Albert, E. Danielson, N. Rifai, P. Ridker. Journal of the American Medical Association (JAMA), 2001

1,611 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/4f810001f3183d356b256f52ddcbb81884d1fca6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. J. Kiecolt-Glaser
2. R. Glaser
3. S. Daniels
4. S. Grundy

In Epidemiology

1. R. Stocker
2. S. Grundy
3. J. Keaney

In Surgery

1. R. Stocker
2. S. Grundy
3. J. Keaney

Citations in the corpus

• Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. (2010, background): “Statins are proposed to have antiinflammatory effects in addition to lipid-lowering effects (Albert et al., 2001).”
• Depression and immune function: central pathways to morbidity and mortality. (2002, background): “A prospective trial of statins produced reductions in CRP, providing evidence that these drugs have anti-inflammatory effects in addition to their ability to lower lipids [45].”
• Role of oxidative modifications in atherosclerosis. (2004, background): “In large part, this prediction has already been fulfilled as lipid-lowering (7), smoking cessation (698), weight loss (1109) and improved glucose control (775) have all been associated with a reduction in circulating markers of inflammation.”